Drug Manufacture BTIG’s 2H 2023 Healthcare Picks include AcumenBy MohamedMis2July 25, 2023 BTIG, a leading financial services firm, has recently revealed its top healthcare picks for the second half of 2023. Among…
Consumer Defensive Humacyte Stock Soars After $160M FundingBy MohamedMis2July 3, 2023 Durham-based company Humacyte experienced a significant boost in its stock prices, surging by 10 percent. Following a remarkable $160 million…
